Medtronic Inc (MDT)

Medtronic Inc (MDT-N) has garnered a mix of opinions from experts. One expert sees the company benefiting from advancements in AI technologies, suggesting that boomers continuing to operate in the market serves as a tailwind for growth. Another expert expresses a more cautious outlook, highlighting that while MDT is currently experiencing a positive short- to medium-term phase and is positioned to compete strongly against peers like Boston Scientific, it may lack the research and development prowess to sustain its leadership over the long term. Despite being diversified in its product offerings, which is a strength compared to competitors focused solely on specific device categories, there are concerns about MDT's market position. Upcoming product launches and a perceived undervaluation, with the stock's price-to-earnings ratio being attractive, may support the stock for the next 12-18 months; however, the long-term outlook remains uncertain.